Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane, Carboplatin, and Herceptin in Advanced HER2+ Breast Cancer
NCT00093145Phase 2Completed
- Sponsor
- Celgene Corporation
- Start
- Jun 2004
- Primary completion
- Oct 2008
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in breast cancer, sponsored by Celgene Corporation. Started Jun 2004; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00093145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00093145.